Division of Endocrinology and Metabolism, Department of Medicine, School of Medicine, University of Pittsburgh, MUH N810, 3459 Fifth Ave, Pittsburgh, PA 15213, USA.
JAMA. 2010 Oct 27;304(16):1795-802. doi: 10.1001/jama.2010.1505. Epub 2010 Oct 9.
The prevalence of severe obesity is increasing markedly, as is prevalence of comorbid conditions such as hypertension and type 2 diabetes mellitus; however, apart from bariatric surgery and pharmacotherapy, few clinical trials have evaluated the treatment of severe obesity.
To determine the efficacy of a weight loss and physical activity intervention on the adverse health risks of severe obesity.
DESIGN, SETTING, AND PARTICIPANTS: Single-blind randomized trial conducted from February 2007 through April 2010 at the University of Pittsburgh. Participants were 130 (37% African American) severely obese (class II or III) adult participants without diabetes recruited from the community.
One-year intensive lifestyle intervention consisting of diet and physical activity. One group (initial physical activity) was randomized to diet and physical activity for the entire 12 months; the other group (delayed physical activity) had the identical dietary intervention but with physical activity delayed for 6 months.
Changes in weight. Secondary outcomes were additional components comprising cardiometabolic risk, including waist circumference, abdominal adipose tissue, and hepatic fat content.
Of 130 participants randomized, 101 (78%) completed the 12-month follow-up assessments. Although both intervention groups lost a significant amount of weight at 6 months, the initial-activity group lost significantly more weight in the first 6 months compared with the delayed-activity group (10.9 kg [95% confidence interval {CI}, 9.1-12.7] vs 8.2 kg [95% CI, 6.4-9.9], P = .02 for group × time interaction). Weight loss at 12 months, however, was similar in the 2 groups (12.1 kg [95% CI, 10.0-14.2] vs 9.9 kg [95% CI, 8.0-11.7], P = .25 for group × time interaction). Waist circumference, visceral abdominal fat, hepatic fat content, blood pressure, and insulin resistance were all reduced in both groups. The addition of physical activity promoted greater reductions in waist circumference and hepatic fat content.
Among patients with severe obesity, a lifestyle intervention involving diet combined with initial or delayed initiation of physical activity resulted in clinically significant weight loss and favorable changes in cardiometabolic risk factors.
clinicaltrials.gov Identifier: NCT00712127.
严重肥胖的患病率显著增加,高血压和 2 型糖尿病等合并症的患病率也在增加;然而,除了减肥手术和药物治疗外,很少有临床试验评估严重肥胖的治疗方法。
确定减肥和体育活动干预对严重肥胖不良健康风险的疗效。
设计、设置和参与者:2007 年 2 月至 2010 年 4 月在匹兹堡大学进行的单盲随机试验。参与者为 130 名(37%为非裔美国人)严重肥胖(II 类或 III 类)的成年参与者,无糖尿病,从社区招募。
为期 1 年的强化生活方式干预,包括饮食和体育活动。一组(初始体力活动)被随机分配在整个 12 个月内进行饮食和体力活动;另一组(延迟体力活动)接受相同的饮食干预,但体力活动延迟 6 个月。
体重变化。次要结局是包括心血管代谢风险在内的其他组成部分,包括腰围、腹部脂肪组织和肝内脂肪含量。
在随机分配的 130 名参与者中,有 101 名(78%)完成了 12 个月的随访评估。尽管两组在 6 个月时都显著减轻了体重,但初始活动组在头 6 个月内比延迟活动组减轻了更多的体重(10.9 公斤[95%置信区间{CI},9.1-12.7]比 8.2 公斤[95%CI,6.4-9.9],P=0.02 组×时间交互作用)。然而,两组在 12 个月时的体重减轻相似(12.1 公斤[95%CI,10.0-14.2]比 9.9 公斤[95%CI,8.0-11.7],P=0.25 组×时间交互作用)。两组的腰围、内脏腹部脂肪、肝内脂肪含量、血压和胰岛素抵抗均有所降低。体力活动的加入促进了腰围和肝内脂肪含量的更大减少。
在严重肥胖患者中,涉及饮食和初始或延迟开始体育活动的生活方式干预可导致临床显著的体重减轻和心血管代谢风险因素的有利变化。
clinicaltrials.gov 标识符:NCT00712127。